Argonaute protein mutant and use thereof
AssigneeBerry Genomics Co., Ltd.
InventorsJianguang ZHANG, Aiping MAO
Life of this patent
Estimating the term…
Loading patent…
AssigneeBerry Genomics Co., Ltd.
InventorsJianguang ZHANG, Aiping MAO
Estimating the term…
The present invention relates to a mutant of Argonaute protein lacking a DNA cleavage activity but having a DNA binding activity, wherein the mutation of the mutant is located in a PIWI domain. The present invention also relates to a use based on the protein mutant, especially in enrichment of a target DNA and construction of sequence libraries. Therefore, the present invention also relates to a method for enrichment of a target DNA, comprising the following steps: (a) designing a guide sequence for a specific sequence in the target DNA; (b) binding the mutant according to the present invention, the guide sequence and the target DNA to obtain a mutant-guide sequence-target DNA ternary complex; (c) capturing the mutant-guide sequence-target DNA ternary complex through a capture medium; and (d) separating the target DNA from the captured mutant-guide sequence-target DNA ternary complex to obtain an enriched target DNA.
1-39. (canceled)
A mutant of Argonaute protein, having a DNA binding activity but lacking a DNA cleavage activity, wherein the mutation of the mutant is located in a PIWI domain.
Dependencies are inferred from the claim text.